DNA’s Roberto Collazo-Maldonado, MD in conjunction with Justin Horowitz, Pharm.D, recently published an article in the Methodist GME Journal. It covers current therapy recommendations for CKD patients with anemia as well as exciting alternatives on the horizon. These new therapies are a very exciting topic in nephrology and have the potential to change the way anemia of CKD is treated in the near future. Read full article».
